1. India Stocks

  2. •

    Finance

  3. •

    Financial conglomerates
Amerise Biosciences Limited

Amerise Biosciences Limited

BBSE:AMERISE
0.81
INR
+0.03
(+3.85%)
-0.01EPS
54.18MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.18
- -
- -
1.36
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.01
- -
-0.14
- -
- -
-0.02
-0.05
0.08
-0.02
-0.02
- -
- -
-0.01
Free Cash Flow per Basic Share
0.41
0.04
0.16
-0.54
-0.01
-0.27
0.74
-0.06
0.01
-0.02
-0.03
0.46
-0.16
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1
0.99
0.99
0.85
0.84
0.84
0.82
0.77
0.85
0.84
0.81
0.81
0.82
- -
Tangible Book Value per Share
1
0.99
0.99
0.85
0.84
0.84
0.82
0.77
0.85
0.84
0.81
0.81
0.82
- -
Basic Weighted Avg Shares
66
66
66
66
66
66
66
66
66
66
66
66
66
69
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
12
- -
- -
90
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
0.35
- -
- -
-0.22
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
-9
- -
- -
-1
-3
5
-1
-1
- -
- -
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
25
21.84
- -
Profit Margin (%)
- -
- -
- -
- -
- -
0.35
- -
- -
6.1
- -
- -
- -
- -
- -
Working Capital
20
37
1
27
27
45
-6
-5
- -
- -
- -
-31
-14
- -
LT Debt
6
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
Total Equity
66
66
65
56
56
56
54
51
56
55
54
54
54
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
0.07
- -
- -
-0.37
- -
- -
0.1
0.3
- -
Return on Capital (%)
- -
- -
- -
- -
- -
0.07
- -
- -
10.16
- -
- -
0.11
0.3
- -
Return on Common Equity (%)
-0.39
-0.72
-0.43
-15.5
-0.38
0.07
-2.71
-6.41
10.24
-2.13
-2.68
0.11
0.3
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
66
66
66
Market Capitalization
40
39
54

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
6
- -
Cash, Cash Equivalents & STI
- -
6
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
20
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.71%
1.29%
0.3%
Free Cash Flow
48.46%
-489.93%
-134.41%
Net Income, GAAP
-85.96%
-56.62%
182.46%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.01
-0.01
- -
0.02
- -
2026
- -
-0.01
- -
0.01
- -
2027
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Albert Hines
Full Time Employees
- -
Sector
Finance
Industry
Financial conglomerates
Address
24, Laxmi Chambers Ahmedabad GU India 380014
IPO Date
Mar 15, 1996
Website
amerisebiosciencesltd.life
Similar Companies
Strategy Inc (NASDAQ:MSTR)
BitMine Immersion Technologies, Inc. (NYSE:BMNR)
Strive, Inc. (NASDAQ:ASST)
Hyperliquid Strategies Inc (NASDAQ:PURR)
Stablecoin Development Corporation (AMEX:SDEV)
Jio Financial Services Limited (NSE:JIOFIN)
Business
Amerise Biosciences Ltd (AMERISE.BO) operates as a biotechnology company focused on research and development in healthcare solutions; however, it currently maintains no significant operations. The company offers innovative biopharmaceutical products targeting various medical conditions, with an emphasis on enhancing patient outcomes through sustainable and quality-driven advancements in the Indian biotech sector. Previously engaged in commodity trading, plastic products, decorative laminates, boards, construction equipment, and agricultural equipment manufacturing, it now prioritizes biotechnology amid low revenue generation of approximately 0.32 crore rupees and inconsistent profitability. Amerise Biosciences serves consumers and healthcare providers primarily in India, with potential expansion in digital services and R&D initiatives. Incorporated in 1984 and headquartered at 24 Laxmi Chambers, Navjeevan Press Road, Ahmedabad, Gujarat, India, it changed its name from Amradeep Industries Limited in December 2021 to reflect its pivot toward biosciences. Recent developments include reporting a standalone net loss of 0.04 crore rupees for the quarter ended September 2025, alongside board meetings in 2025 to approve unaudited financial results, but no major acquisitions, partnerships, funding rounds, or new product launches have been announced in the last 1-2 years.